Zepbound (tirzepatide) - Eli Lilly
berobenatide (PF-08653944) - Pfizer
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity (clinicaltrials.gov) - Sep 30, 2026 - P3 | N=660 | Not yet recruiting | Sponsor: Pfizer 
New P3 trial • Genetic Disorders • Obesity
http://clinicaltrials.gov/ct2/show/NCT07845500
 
Sep 30, 2026
 
Prev Next